California Doctors Again Press For More Money To Treat Poor Patients
They want the state’s new tobacco tax to help pay for a raise in Medicaid rates, but so far Gov. Jerry Brown has other plans for that money.
The independent source for health policy research, polling, and news.
2,501 - 2,520 of 3,883 Results
They want the state’s new tobacco tax to help pay for a raise in Medicaid rates, but so far Gov. Jerry Brown has other plans for that money.
Democratic senators want the Justice Department to reveal what it knows about ProPublica’s recent report that HHS Secretary Tom Price’s stock trades were under investigation by former U.S. Attorney Preet Bharara before the Trump administration fired him.
Some urologists use March Madness as an opportunity to market vasectomy services, offering men the excuse to sit on the sofa for three days to watch college basketball while they recover.
The Department of Justice is joining a whistleblower lawsuit in a fraud case against UnitedHealth in which damages could top $1 billion.
As Congress and the White House try to strike a bargain on an Obamacare repeal plan, the insurance industry likes what it’s seeing.
Republicans and Democrats don’t agree on much these days, but both parties want to keep the health law’s provision to allow adults to stay on their parents’ plan until age 26. But that could be hurting the marketplace’s insurance pools.
The Government Accountability Office said it will investigate potential abuses of the orphan drug program, which offers incentives to drugmakers to develop medicines for rare diseases.
The legislation, passed by the House, would allow nationwide “association health plans.” But consumer advocates have raised serious concerns about such options in the past.
Is Republican Rep. Mark Meadows the man who would kill "Trumpcare"? He enjoys strong support in his gerrymandered western North Carolina district as he leads conservative opposition to the GOP’s plan for repealing and replacing Obamacare.
Lesser-known provisions in the Republican proposal to replace the Affordable Care Act would push some Medicaid enrollees out of coverage and cause financial pain for others.
Spending on consumer advertising by drugmakers has increased 62 percent since 2012.
Matching with a residency program had an added layer of stress this year for doctors-in-training from the countries affected by President Donald Trump's travel ban.
The HHS Secretary bought stock in companies that stood to benefit from legislation he voted for and sponsored as a Georgia congressman.
A cholesterol-lowering drug called Repatha cuts the risk of heart attacks, strokes and heart-related death by 20 percent, according to a new study.
Marathon, maker of an expensive treatment for Duchenne muscular dystrophy, sells the drug for $140 million in cash and stock to PTC Therapeutics.
A growing number of patients fail to fill prescriptions because the cost of cancer drugs is too high.
The numbers show that President Trump’s choice for FDA commissioner, Scott Gottlieb, has long-standing ties to pharmaceutical companies as a board member or consultant and that he had to recuse himself multiple times while working at the FDA.
For patients killed or maimed by medical errors, doctors and hospitals still often deny wrongdoing. But newer programs offering prompt disclosure of medical errors, an apology and compensation for them or their families are growing.
In the heated political arguments as Republicans rush to repeal and replace the Affordable Care Act, some facts can get buried.
Not being officially admitted — a status known as observation care — can have financial consequences for beneficiaries, and patients had often complained they were not informed.
© 2026 KFF